
The Heredia facility grew by 16,000 square feet, adding new extrusion equipment and production lines. This allows the site to produce sterile packaging, such as Tyvek-based pouches, header bags, and lids, while increasing output for extruded medical tubing. The expansion supports a 24/7 production schedule to meet the needs of both existing and new clients.
Certified under ISO 13485:2016 and ISO 9001:2015 standards, the facility maintains rigorous quality protocols, with its technical, assembly, and packaging staff adhering to industry benchmarks. The upgrade positions DuPont to deliver high-quality solutions for medical device manufacturers seeking reliable supply chain partners.
James Chambers, Senior Vice President and General Manager for Fluids & Flexibles at Spectrum Plastics Group, a DuPont Business, stated: “With this expansion, we are now the first company in Costa Rica and the Caribbean to produce fluid management and sterile packaging offerings for the medical device industry. This significantly enhances our robust, growing portfolio of unmatched offerings and capabilities as a trusted supply chain partner to leading global healthcare companies.”
DuPont’s healthcare portfolio includes extruded tubing, advanced catheter assembly, medical balloons, skin contact devices, smart wearables, additive manufacturing, laser processing, precision injection-molding, medical device fabrication, machining, and sterile packaging using Tyvek. The Heredia expansion strengthens the company’s ability to provide comprehensive solutions for medical device applications.
The facility’s strategic location in Costa Rica supports efficient distribution across the Americas, addressing growing demand for sterile packaging and medical tubing. By investing in advanced manufacturing capabilities, DuPont reinforces its commitment to innovation and quality in the healthcare sector, fostering economic growth in the region through job creation and enhanced production capacity.
This expansion aligns with industry trends toward localized production and reliable supply chains, ensuring DuPont can meet the evolving needs of global healthcare companies. The Heredia site’s upgraded infrastructure and certifications position it as a key hub for medical device manufacturing, supporting both regional and international markets with high-performance products.